JUNE 29, 2017 BY FINK DENSFORD BoneSupport said last week it closed its initial public offering, raising a total of approximately $57.1 million (SEK 500 million), not including an over-allotment option. The Swedish company, which is developing the Cerament G injectable antibiotic-eluting bone graft substitute, said it floated approximately 17.2 […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone